Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Emberton

Showing results (81-90 of 474) with videos related to

Pageof 48
Sort By:
Acta Biomaterialia|April 30, 2013
A novel tissue engineered three-dimensional in vitro colorectal cancer modelAgata Nyga, Marilena Loizidou, Mark Emberton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2010
Active surveillance: is there a need for better risk stratification at the outset?Paras B Singh, Hashim U Ahmed, Mark Emberton
BJU International|August 27, 2004
The relationship between volume and outcome in urological surgeryMartin Nuttall, Jan Van Der Meulen, Mark Emberton
Journal of Clinical Epidemiology|February 21, 2006
Charlson scores based on ICD-10 administrative data were valid in assessing comorbidity in patients undergoing urological cancer surgeryMartin Nuttall, Jan van der Meulen, Mark Emberton
The Journal of Urology|February 21, 2012
Re: Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging: P. A. Pinto, P. H. Chung, A. R. Rastinehad, A. A. Baccala, Jr., J. Kruecker, C. J. Benjamin, S. Xu, P. Yan, S. Kadoury, C. Chua, J. K. Locklin, B. Turkbey, J. H. Shih, S. P. Gates, C. Buckner, G. Bratslavsky, W. M. Linehan, N. D. Glossop, P. L. Choyke and B. J. Wood J Urol 2011; 186: 1281-1285Nicola L Robertson, Caroline M Moore, Mark Emberton
Journal of Health Psychology|May 1, 2004
Men and chronic illness: a qualitative study of LUTSKenneth Gannon, Lesley Glover, Marie O'Neill, et al.
BJU International|August 27, 2004
Men's experiences of having lower urinary tract symptoms: factors relating to botherLesley Glover, Kenneth Gannon, Joanne McLoughlin, et al.
European Urology|July 18, 2006
How good is MRI at detecting and characterising cancer within the prostate?Alexander P S Kirkham, Mark Emberton, Clare Allen
BMJ Open|December 16, 2020
Detailing sexual outcomes after treatment of localised prostate cancer with focal therapy using various energy sources: protocol for a mixed-methods studyGaelle Fiard, Daniel Kelly, Tet Yap, et al.
Current Opinion in Urology|June 1, 2017
The role of the multiparametric MRI in the diagnosis of prostate cancer in biopsy-naïve menAdrian Rhudd, Jean McDonald, Mark Emberton, et al.
Pageof 48

Showing results (81-90 of 474) with videos related to

Sort By:
Pageof 48
Acta Biomaterialia|April 30, 2013
A novel tissue engineered three-dimensional in vitro colorectal cancer modelAgata Nyga, Marilena Loizidou, Mark Emberton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2010
Active surveillance: is there a need for better risk stratification at the outset?Paras B Singh, Hashim U Ahmed, Mark Emberton
BJU International|August 27, 2004
The relationship between volume and outcome in urological surgeryMartin Nuttall, Jan Van Der Meulen, Mark Emberton
Journal of Clinical Epidemiology|February 21, 2006
Charlson scores based on ICD-10 administrative data were valid in assessing comorbidity in patients undergoing urological cancer surgeryMartin Nuttall, Jan van der Meulen, Mark Emberton
The Journal of Urology|February 21, 2012
Re: Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging: P. A. Pinto, P. H. Chung, A. R. Rastinehad, A. A. Baccala, Jr., J. Kruecker, C. J. Benjamin, S. Xu, P. Yan, S. Kadoury, C. Chua, J. K. Locklin, B. Turkbey, J. H. Shih, S. P. Gates, C. Buckner, G. Bratslavsky, W. M. Linehan, N. D. Glossop, P. L. Choyke and B. J. Wood J Urol 2011; 186: 1281-1285Nicola L Robertson, Caroline M Moore, Mark Emberton
Journal of Health Psychology|May 1, 2004
Men and chronic illness: a qualitative study of LUTSKenneth Gannon, Lesley Glover, Marie O'Neill, et al.
BJU International|August 27, 2004
Men's experiences of having lower urinary tract symptoms: factors relating to botherLesley Glover, Kenneth Gannon, Joanne McLoughlin, et al.
European Urology|July 18, 2006
How good is MRI at detecting and characterising cancer within the prostate?Alexander P S Kirkham, Mark Emberton, Clare Allen
BMJ Open|December 16, 2020
Detailing sexual outcomes after treatment of localised prostate cancer with focal therapy using various energy sources: protocol for a mixed-methods studyGaelle Fiard, Daniel Kelly, Tet Yap, et al.
Current Opinion in Urology|June 1, 2017
The role of the multiparametric MRI in the diagnosis of prostate cancer in biopsy-naïve menAdrian Rhudd, Jean McDonald, Mark Emberton, et al.
Pageof 48